Selcuk Ecza Deposu Ticaret Ve Sanayi A.s. · BIST:SELEC

Selcuk Ecza Deposu Ticaret Ve Sanayi A.s — Q1 2026 Earnings Presentation

23 slides from Selcuk Ecza Deposu Ticaret Ve Sanayi A.s's earnings presentation, 2026

  1. Slide 1: 2026 3 Months Investor Presentation

    2026 3 MONTHS INVESTOR PRESENTATION

  2. Slide 2: Contents

    2026 3 Months / Investor Presentation 1 Contents  Key Strengths  Regulatory and Operational Dynamics  Market Position  Profitability  Cash & Liquidity  Working Capital  Operational Efficiency  Cost Structure  Capital Expenditures & Free Cash Flow  Appendix: Financial Summary

  3. Slide 3: Key Strengths: Strong Market Position and Operational Scale

    2026 3 Months / Investor Presentation 2 Key Strengths Strong Market Position and Operational Scale Leading Market Position  Market leadership with a ~38% market share (TRY-based) as of 1Q26  Over 60 years of industry experience and long-term supplier relationships  Significant scale advantages su

  4. Slide 4: Key Strengths: Financial Strength and Balance Sheet Structure

    2026 3 Months / Investor Presentation 3 Key Strengths Financial Strength and Balance Sheet Structure Strong Balance Sheet  Solid balance sheet supported by a strong equity base  Diversified funding sources (including access to the commercial paper market)  Strong liquidity metrics and a controlle

  5. Slide 5: Key Strengths: Resilient Business Model and Growth Potential

    2026 3 Months / Investor Presentation 4 Key Strengths Resilient Business Model and Growth Potential Resilient Business Model  Defensive industry structure: pharmaceutical demand is relatively resilient to economic cycles  Predictable and stable revenue structure within the regulatory framework  S

  6. Slide 6: Regulatory and Operational Dynamics

    2026 3 Months / Investor Presentation 5 Regulatory and Operational Dynamics Regulatory and Pricing Risk  Reference Country Pricing System  Periodic Euro Value (DAD) Adjustments  Public Reimbursement Policies Macro and Cost Dynamics  Inflation-driven cost increases  Timing of foreign exchange pa

  7. Slide 7: Leading Market Share

    2026 3 Months / Investor Presentation 6 Leading Market Share * Source: IQVIA, TRY-based market share data

  8. Slide 8: Profitability Metrics

    2026 3 Months / Investor Presentation 7 Profitability Metrics (Million TRY) 1Q26 1Q25 Change Revenue 51,925.84 49,060.82 5.84% Gross Profit 6,133.40 3,938.71 55.72% Gross Profit Margin 11.81% 8.03% +378 bps EBITDA 3,560.06 1,232.89 188.76% EBITDA Margin 6.86% 2.51% +435 bps Net Profit 1,539.51 2.79

  9. Slide 9: Revenue

    2026 3 Months / Investor Presentation 8 Revenue 5.84% (Million TRY)

  10. Slide 10: Gross Profit

    2026 3 Months / Investor Presentation 9 Gross Profit 55.72% (Million TRY)

  11. Slide 11: EBITDA

    2026 3 Months / Investor Presentation 10 EBITDA 188.76% * EBIT and EBITDA are analytical metrics derived from the Company’s financial statements to reflect operating profitability. The calculation excludes financing-related income and expenses, maturity and foreign exchange differences, interest inc

  12. Slide 12: Net Profit

    2026 3 Months / Investor Presentation 11 Net Profit 55,031.19% (Million TRY)

  13. Slide 13: Cash and Liquidity Overview

    2026 3 Months / Investor Presentation 12 Cash and Liquidity Overview (Million TRY) 1Q26 2025 Cash and Financial Investments 13,384.03 8,326.22 Financial Debt 6,084.09 875.77 Net Cash * 7,299.94 7,450.45 * Net Cash = Cash and Financial Investments – Financial Debt  The Company preserved its net cash

  14. Slide 14: Working Capital

    2026 3 Months / Investor Presentation 13 Working Capital (Million TRY) 1Q26 2025 Trade Receivables 49,912.61 46,837.79 Inventories 19,040.29 18,358.34 Trade Payables 53,194.38 52,077.25 Working Capital 15,758.53 13,118.88 Working Capital / Sales (%) 7.59 6.69 * The 1Q26 ratio is based on annualized

  15. Slide 15: Operational Data

    2026 3 Months / Investor Presentation 14 Operational Data 110 warehouses | ~2,400 vehicles | ~6,000 employees

  16. Slide 16: Extensive Warehouse Network & Distribution Infrastructure

    2026 3 Months / Investor Presentation 15 Extensive Warehouse Network & Distribution Infrastructure Main Regional Total Warehouse Warehouse Selçuk Ecza 23 73 96 As Ecza 4 10 14 Group Total 27 83 110

  17. Slide 17: Operational Efficiency Metrics

    2026 3 Months / Investor Presentation 16 Operational Efficiency Metrics 1Q26 1Q25 Revenue (Million TRY) 51,925.84 49,060.82 # of Employees 5,985 6,226 # of Warehouses 110 112 OpEx / Revenue (%) 5.58 6.31 Personnel Expense / Sales (%) 3.94 4.48 # of Employees / # of Warehouses 54.41 55.59 Revenue / #

  18. Slide 18: Operating Expense Breakdown

    2026 3 Months / Investor Presentation 17 Operating Expense Breakdown 1Q26 vs 1Q25 Operating Expenses 1Q26 % 1Q25 % (%) Personnel expense 2,048,370,303 70.69 2,197,141,820 71.02 -6.77 Depreciation and amortization expense 248,863,988 8.59 228,154,217 7.38 9.08 Fuel expense 122,750,642 4.24 125,705,49

  19. Slide 19: Capital Expenditures and Free Cash Flow

    2026 3 Months / Investor Presentation 18 Capital Expenditures and Free Cash Flow 1Q26 1Q25 Revenue (Million TRY) 51,925.84 49,060.82 Cash Flows From Operating Activities (Million TRY) -1,927.34 5,733.42 CapEx (Million TRY) * 146.58 205.46 Free Cash Flow -2,073.91 5,527.95 CapEx / Revenue (%) 0.28 0.

  20. Slide 20: Appendix: Financial Summary - Consolidated Income Statement

    2026 3 Months / Investor Presentation 19 Appendix: Financial Summary Consolidated Income Statement (Million TRY) 1Q26 1Q25 REVENUE 51,925.84 49,060.82 Cost Of Sales (-) -45,792.44 -45,122.10 GROSS PROFIT 6,133.40 3,938.71 OPEX -2,897.67 -3,093.53 Other Operating Income / Expenses (Net) -155.40 -289.

  21. Slide 21: Appendix: Financial Summary - Consolidated Balance Sheet

    2026 3 Months / Investor Presentation 20 Appendix: Financial Summary Consolidated Balance Sheet (Million TRY) ASSETS 31.03.2026 31.12.2025 LIABILITIES AND EQUITY 31.03.2026 31.12.2025 Cash And Cash Equivalents & 13,384.03 8,326.22 Short-Term Payables 5,973.67 737.72 Financial Investments Trade Recei

  22. Slide 22: Notice

    2026 3 Months / Investor Presentation 21 Notice IAS 29 Application Pursuant to the resolution of the Capital Markets Board of Türkiye (CMB) dated 28 December 2023 and numbered 81/1820, issuers applying Turkish Financial Reporting Standards (TFRS), which are fully compliant with IFRS, are required to

  23. Slide 23: Investor Relations & Capital Markets Department

    Selçuk Ecza Deposu Tic. ve San. A.Ş. Borsa İstanbul: SELEC Investor Relations & Capital Markets Department www.selcukecza.com.tr Reuters: SELEC.IS yiselec@selcukecza.com.tr Tel: +90 216 554 0554 Bloomberg: SELEC.TI Tel: +90 216 554 0554 Fax: +90 216 554 0517

Selçuk Ecza Deposu Ticaret ve Sanayi A.Ş. — Q1 2026 Earnings Presentation on 6ix